NEX-I, a biotech developing therapies to overcome resistance to cancer immunotherapy, is seeking a Kosdaq listing, with its ...

Adults with type 2 diabetes on once-weekly semaglutide injection 1 mg whose dose was increased to 2 mg had a 6 percent lower ...

Physical AI could gain an early foothold in urology, where standardized procedures and extensive imaging and surgical video ...

MSD Korea is bringing a subcutaneous formulation of its blockbuster cancer drug Keytruda to Korea, offering patients and ...

Korean researchers have identified ETS1 as a key driver of metastasis and immune evasion in head and neck squamous cell ...

NeoImmuneTech’s U.S. partner Tolerance Bio has added a clinical-stage IL-33 antibody to its thymus-focused pipeline alongside ...

Korea may need 12 to 20 proton therapy centers, each capable of treating about 1,000 patients a year, based on estimates of ...

Sky Labs and the Korean Society of Hypertension are launching a joint study using about 300,000 real-world cuffless blood ...

The number of chronic kidney disease patients in Korea has more than doubled over the past decade, while medical costs more ...

Shares of Ariio Holdings plunged about 18 percent in early trading Wednesday after the company scrapped its planned merger ...

SK chemicals said Wednesday it received an AAA rating in MSCI's latest environmental, social and governance assessment, up ...

Hanmi Pharmaceutical said on Tuesday that it will regain global rights to its cancer drug belvarafenib after Genentech ...